PharmaShots | Incisive News in 3 Shots

Subscribe Now

macular-degenerative diseases

Formycon and Bioeq Report Submission of BLA to the US FDA for FYB201 (biosimilar- ranibizumab)

Formycon and Bioeq Report Submission of BLA to the US FDA for FYB201 (biosimilar- ranibizumab)

August 5, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us